Information about Idorsia’s active clinical trials is available on www.clinicaltrials.gov. Requests for access to an Idorsia investigational drug via its Discretionary Compassionate Use Program must be made by a qualified physician by sending a message via the contact form including the investigational treatment name and the patient’s disease or condition. To maintain the patient's privacy, no personally identifiable information must be included (no personal data of the patient such as e.g. patient's name, social security number, address, date of birth) in the request. The request will be acknowledged within 2 business days upon receipt.
In processing your personal data, Idorsia will fully comply with internationally recognized standards of data protection. In doing so, Idorsia ensures compliance of its staff with strict standards of security and confidentiality.